JPRN-UMIN000046317招募中未知
Study of the facial expressions of care recipients with and without the use of nursing care devices for transfer support - Study of the facial expressions of care recipients with and without the use of nursing care devices for transfer support
ational Center for Geriatrics and Gerontology0 个研究点目标入组 150 人开始时间: 2021年12月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The exclusion criteria are the same as the application criteria for the commercial devices; Hug has no application criteria on the part of the caregivers, and care recipients weighing 100 kg or more and those who cannot sit up are excluded. There are no specific exclusion criteria for Resyone. 2. Other persons who are deemed inappropriate by the Research Director or Research Divider.
研究者
相似试验
已完成
不适用
Perception of Facial Expression in Subjects With and Without Crow's Feet LinesHealthy VolunteersNCT02417077Allergan393
招募中
不适用
Abnormal processing of facial expression and perception in neurological disorders and its pathological basisJPRN-UMIN000036138Department of Cell Physiology Kyorin University30
尚未招募
不适用
Facial mimicry and emotion processing in patients with somatoform pain disorder - an EEG / EMG studyF45.4Persistent somatoform pain disorderDRKS00025053VR-Klinikum DüsseldorfKliniken der Heinrich-Heine-Universität DüsseldorfKlinik für Psychosomatische Medizin und Psychotherapie80
进行中（未招募）
1 期
Exploratory study to assess facial tolerability after daily application of several concentrations and formulations containing CD5789 in acne subjectsEUCTR2010-024214-54-BEGALDERMA R&D SNC60
进行中（未招募）
不适用
Exploratory study to assess facial tolerability after daily application of several concentrations and formulations containing CD5789 in acne subjectsAcne vulgarisMedDRA version: 13.1Level: PTClassification code 10000496Term: AcneSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2010-024214-54-HUGALDERMA R&D SNC60